Wealthcare Advisory Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,753
Closed -$325K 1162
2026
Q1
$325K Sell
2,753
-2,154
-44% -$266K 0.01% 849
2025
Q4
$617K Sell
4,907
-18
-0.4% -$2.35K 0.01% 629
2025
Q3
$721K Buy
4,925
+947
+24% +$143K 0.02% 580
2025
Q2
$620K Sell
3,978
-328
-8% -$52K 0.01% 594
2025
Q1
$709K Buy
4,306
+9
+0.2% +$1.5K 0.02% 509
2024
Q4
$700K Sell
4,297
-63
-1% -$11.3K 0.02% 500
2024
Q3
$852K Sell
4,360
-262
-6% -$48.3K 0.02% 457
2024
Q2
$801K Buy
4,622
+219
+5% +$36.4K 0.03% 443
2024
Q1
$745K Buy
4,403
+39
+0.9% +$7.3K 0.02% 455
2023
Q4
$861K Sell
4,364
-207
-5% -$36.6K 0.03% 354
2023
Q3
$795K Sell
4,571
-105
-2% -$19.1K 0.04% 319
2023
Q2
$805K Buy
4,676
+61
+1% +$10.5K 0.04% 336
2023
Q1
$768K Sell
4,615
-15
-0.3% -$2.46K 0.03% 348
2022
Q4
$679K Buy
4,630
+229
+5% +$33.9K 0.03% 349
2022
Q3
$653K Buy
4,401
+372
+9% +$62.2K 0.04% 302
2022
Q2
$692K Sell
4,029
-18
-0.4% -$3.11K 0.04% 260
2022
Q1
$763K Buy
4,047
+7
+0.2% +$1.38K 0.05% 233
2021
Q4
$986K Buy
4,040
+197
+5% +$43.1K 0.06% 197
2021
Q3
$746K Buy
3,843
+52
+1% +$10.5K 0.05% 239
2021
Q2
$706K Buy
3,791
+39
+1% +$6.77K 0.05% 248
2021
Q1
$591K Buy
3,752
+466
+14% +$73.8K 0.04% 259
2020
Q4
$544K Buy
3,286
+41
+1% +$6.67K 0.05% 227
2020
Q3
$537K Buy
3,245
+2
+0.1% +$307 0.06% 190
2020
Q2
$444K Buy
3,243
+122
+4% +$15.9K 0.06% 190
2020
Q1
$367K Buy
3,121
+72
+2% +$9.48K 0.05% 191
2019
Q4
$404K Buy
3,049
+2,859
+1,505% +$355K 0.05% 198
2019
Q3
$24K Hold
190
﹤0.01% 708
2019
Q2
$22K Hold
190
﹤0.01% 703
2019
Q1
$19K Hold
190
﹤0.01% 682
2018
Q4
$16K Hold
190
﹤0.01% 692
2018
Q3
$17K Hold
190
﹤0.01% 727
2018
Q2
$16K Buy
190
+37
+24% +$3.12K ﹤0.01% 729
2018
Q1
$13K Sell
153
-14
-8% -$1.1K ﹤0.01% 679
2017
Q4
$12K Buy
167
+13
+8% +$893 ﹤0.01% 646
2017
Q3
$10K Buy
+154
New +$9.65K ﹤0.01% 555

Other funds holding ZTS

Wealthcare Advisory Partners's ZTS Position: Q2 2026 in Review

Wealthcare Advisory Partners sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 2,753 shares — an estimated $325K sold.

Wealthcare Advisory Partners first reported a position in ZTS in Q3 2017 and held it in 35 quarters. The position peaked at $986K in Q4 2021. 271 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Wealthcare Advisory Partners reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 2,753 Zoetis shares in Q2 2026, an estimated $325K.
  • Wealthcare Advisory Partners first reported a position in Zoetis in Q3 2017 and held it in 35 quarters.
  • Wealthcare Advisory Partners's Zoetis position peaked at $986K in Q4 2021.
  • 271 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.